Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells. [electronic resource]
Producer: 20201228Description: 1074-1080 p. digitalISSN:- 1090-2104
- Antineoplastic Agents -- pharmacology
- Cell Death -- drug effects
- Cell Line, Tumor
- Cyclin D2 -- genetics
- Drug Resistance, Neoplasm -- genetics
- Drug Synergism
- Glycogen Synthase Kinase 3 -- antagonists & inhibitors
- Humans
- Imatinib Mesylate -- pharmacology
- Imidazoles -- pharmacology
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Leupeptins -- pharmacology
- Macrocyclic Compounds -- pharmacology
- Myeloid Cell Leukemia Sequence 1 Protein -- antagonists & inhibitors
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors -- pharmacology
- Phosphorylation
- Protein Kinase Inhibitors -- pharmacology
- Protein Phosphatase 2 -- metabolism
- Proteolysis -- drug effects
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- Proto-Oncogene Proteins c-myc -- genetics
- Pyridazines -- pharmacology
- Pyrroles -- pharmacology
- Signal Transduction -- drug effects
- Wortmannin -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.